Posted in | News | Nanofabrication

Owlstone Nanotech to Investigate on Application of Miniaturised FAIMS Technology for UK Defence Ministry

Related Stories

Advance Nanotech, Inc. (OTCBB: AVNA) is pleased to announce that its subsidiary, Owlstone Nanotech Inc. ("Owlstone") has been awarded an $80k contract from an agency of the UK Ministry of Defence for a 3-month investigation into the application of its core miniaturised FAIMS technology in ultra-trace vapor detection.

Pending success of this 3-month proof-of-principle stage there is an opportunity for contract extension to a longer second Phase in which field deployment trials would be undertaken.

Bret Bader, Owlstone's CEO, commented, "We are pleased to have received this contract which is set for delivery and completion during this first quarter of 2010. We are looking forward to working more closely with the MoD on a program that has the potential to demonstrate a novel application for our core technology."

Source: http://www.owlstonenanotech.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Owlstone Nanotech. (2019, February 14). Owlstone Nanotech to Investigate on Application of Miniaturised FAIMS Technology for UK Defence Ministry. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=16285.

  • MLA

    Owlstone Nanotech. "Owlstone Nanotech to Investigate on Application of Miniaturised FAIMS Technology for UK Defence Ministry". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=16285>.

  • Chicago

    Owlstone Nanotech. "Owlstone Nanotech to Investigate on Application of Miniaturised FAIMS Technology for UK Defence Ministry". AZoNano. https://www.azonano.com/news.aspx?newsID=16285. (accessed November 21, 2024).

  • Harvard

    Owlstone Nanotech. 2019. Owlstone Nanotech to Investigate on Application of Miniaturised FAIMS Technology for UK Defence Ministry. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=16285.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback